Daisuke Shimojo

Astellas Pharma (Japan)

Papers

1

Total Citations

22

H-Index

1

About

Daisuke Shimojo is a pioneer in the automation of stem cell biology, with his work centering on induced pluripotent stem cell (iPSC) research and the development of robotic platforms for regenerative medicine. His most notable contribution is the establishment of a robust, fully automated system for iPSC culture and differentiation using the Maholo LabDroid, a humanoid robot designed to perform complex, delicate cell-handling tasks with high precision and reproducibility. This breakthrough, detailed in his 2021 landmark paper (22 citations), directly addresses a critical bottleneck in the field: the need for highly skilled technicians to maintain and differentiate iPSCs. By demonstrating that a robot can reliably execute these intricate protocols, Shimojo has opened the door to scalable, standardized production of patient-specific cells for drug discovery and disease modeling. His work is a cornerstone in the movement toward "laboratory automation 2.0," where artificial intelligence and robotics converge to democratize advanced cell culture. For students and researchers, Shimojo’s vision represents a future where high-throughput, error-free stem cell manufacturing is no longer a manual art, but a reproducible science.

Research Focus

Key Achievements

1
H-Index
1
Papers
22
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Establishment of a Robust Platform for Induced Pluripotent Stem Cell Research Using Maholo LabDroid
22 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Astellas Pharma (Japan)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago